Maven Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,600
Closed -$1.79M 573
2025
Q2
$1.79M Buy
+4,600
New +$1.85M 0.04% 332
2025
Q1
Sell
-2,700
Closed -$996K 848
2024
Q4
$996K Sell
2,700
-1,200
-31% -$502K 0.02% 418
2024
Q3
$2.03M Sell
3,900
-4,100
-51% -$2.19M 0.04% 350
2024
Q2
$4.33M Buy
+8,000
New +$4.23M 0.1% 220
2024
Q1
Sell
-1,600
Closed -$754K 559
2023
Q4
$754K Sell
1,600
-1,000
-38% -$462K 0.02% 550
2023
Q3
$1.13M Sell
2,600
-2,500
-49% -$1.13M 0.01% 579
2023
Q2
$2.27M Buy
5,100
+3,600
+240% +$1.66M 0.03% 265
2023
Q1
$690K Buy
1,500
+300
+25% +$143K 0.01% 562
2022
Q4
$616K Sell
1,200
-6,000
-83% -$3.05M 0.01% 532
2022
Q3
$3.27M Buy
7,200
+6,000
+500% +$2.87M 0.06% 189
2022
Q2
$579K Sell
1,200
-1,900
-61% -$940K 0.02% 536
2022
Q1
$1.52M Sell
3,100
-2,700
-47% -$1.23M 0.05% 244
2021
Q4
$2.69M Buy
5,800
+3,200
+123% +$1.35M 0.08% 142
2021
Q3
$969K Sell
2,600
-4,900
-65% -$1.86M 0.03% 455
2021
Q2
$2.86M Buy
7,500
+5,300
+241% +$2.03M 0.12% 158
2021
Q1
$790K Buy
+2,200
New +$707K 0.04% 499
2020
Q3
Sell
-2,400
Closed -$631K 640
2020
Q2
$631K Buy
+2,400
New +$640K 0.04% 273

Other funds holding ELV

Maven Securities's ELV Position: Q4 2024 in Review

Maven Securities sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 694 shares — an estimated $290K sold.

Maven Securities first reported a position in ELV in Q2 2020 and held it in 8 quarters. The position peaked at $2.53M in Q3 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Maven Securities reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Maven Securities sold 694 Elevance Health shares in Q4 2024, an estimated $290K.
  • Maven Securities first reported a position in Elevance Health in Q2 2020 and held it in 8 quarters.
  • Maven Securities's Elevance Health position peaked at $2.53M in Q3 2022.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Maven Securities's 13F filing for Q4 2024, filed 14 Feb 2025.